CIMATRON LIMITED
|
|||
By: |
/s/ Ilan Erez
|
||
Ilan Erez
|
|||
Chief Financial Officer
|
Exhibit
No.
|
Description
|
99.1
|
Press release announcing results of operations of Cimatron Limited for the quarter and six months ended June 30, 2014.
|
|
·
|
24% year-over-year increase in non-GAAP operating profit for Q2, to a second quarter record of $2.0 million;
|
|
·
|
28% year-over-year increase in non-GAAP net profit for Q2, to a second quarter record of $1.5 million;
|
|
·
|
Record Q2 revenues of $11.8 million, a 6.5% year-over-year increase (4.4% on a constant currency basis);
|
|
·
|
17th consecutive quarter with year-over-year revenue growth on a constant currency basis;
|
|
·
|
Record $7.6 million cash flow from operating activities in the first six months of 2014 leads to end of June net cash balance of $20.4 million or $1.90 per share
|
Company Contact:
|
Investor Relations contact
|
Ilan Erez, Chief Financial Officer
|
Ehud Helft/Kenny Green
|
Cimatron Ltd.
|
GK Investor Relations
|
Tel.; 972-73-237-0114
|
Tel: (US) 1 646 201 9246
|
Email: ilane@cimatron.com
|
Email: Cimatron@gkir.com
|
Three months ended
|
Six months ended
|
|||||||||||||||
June 30,
|
June 30,
|
|||||||||||||||
2014
|
2013
|
2014
|
2013
|
|||||||||||||
Total revenue
|
11,754 | 11,039 | 22,717 | 21,197 | ||||||||||||
Total cost of revenue
|
1,450 | 1,391 | 2,953 | 2,717 | ||||||||||||
Gross profit
|
10,304 | 9,648 | 19,764 | 18,480 | ||||||||||||
Research and development expenses
|
1,871 | 1,758 | 3,786 | 3,486 | ||||||||||||
Selling, general and administrative expenses
|
6,761 | 6,477 | 13,235 | 12,803 | ||||||||||||
Operating income
|
1,672 | 1,413 | 2,743 | 2,191 | ||||||||||||
Financial income (expenses), net
|
35 | (40 | ) | (4 | ) | (24 | ) | |||||||||
Taxes on income
|
(409 | ) | (377 | ) | (759 | ) | (569 | ) | ||||||||
Other
|
(5 | ) | 3 | (26 | ) | 5 | ||||||||||
Net income
|
1,293 | 999 | 1,954 | 1,603 | ||||||||||||
Less: Net (income) loss attributable to the noncontrolling interest
|
- | 3 | (10 | ) | 3 | |||||||||||
Net income attributable to Cimatron's shareholders
|
$ | 1,293 | $ | 1,002 | $ | 1,944 | $ | 1,606 | ||||||||
Net income per share - basic and diluted
|
$ | 0.12 | $ | 0.11 | $ | 0.18 | $ | 0.17 | ||||||||
Weighted average number of shares outstanding
|
||||||||||||||||
Basic EPS (in thousands)
|
10,751 | 9,362 | 10,741 | 9,355 | ||||||||||||
Diluted EPS (in thousands)
|
10,761 | 9,362 | 10,744 | 9,360 |
Three months ended
|
Six months ended
|
|||||||||||||||||||||||||||||||||||||||||||||||
June 30,
|
June 30,
|
|||||||||||||||||||||||||||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||||||||||||||||||||||||||||||||||
GAAP
|
Adj.
|
NON-GAAP
|
GAAP
|
Adj.
|
NON-GAAP
|
GAAP
|
Adj.
|
NON-GAAP
|
GAAP
|
Adj.
|
NON-GAAP
|
|||||||||||||||||||||||||||||||||||||
Total revenue
|
11,754 | - | 11,754 | 11,039 | - | 11,039 | 22,717 | - | 22,717 | 21,197 | - | 21,197 | ||||||||||||||||||||||||||||||||||||
Total cost of revenue (1)
|
1,450 | (147 | ) | 1,303 | 1,391 | (147 | ) | 1,244 | 2,953 | (294 | ) | 2,659 | 2,717 | (294 | ) | 2,423 | ||||||||||||||||||||||||||||||||
Gross profit
|
10,304 | 147 | 10,451 | 9,648 | 147 | 9,795 | 19,764 | 294 | 20,058 | 18,480 | 294 | 18,774 | ||||||||||||||||||||||||||||||||||||
Research and development expenses (2)
|
1,871 | (12 | ) | 1,859 | 1,758 | - | 1,758 | 3,786 | (24 | ) | 3,762 | 3,486 | - | 3,486 | ||||||||||||||||||||||||||||||||||
Selling, general and administrative expenses
|
6,761 | 6,614 | 6,477 | 6,445 | 13,235 | 12,951 | 12,803 | 12,718 | ||||||||||||||||||||||||||||||||||||||||
Non-cash amortization of acquired intangible assets
|
- | (32 | ) | - | (85 | ) | ||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation
|
(147 | ) | - | (284 | ) | - | ||||||||||||||||||||||||||||||||||||||||||
Operating income
|
1,672 | 306 | 1,978 | 1,413 | 179 | 1,592 | 2,743 | 602 | 3,345 | 2,191 | 379 | 2,570 | ||||||||||||||||||||||||||||||||||||
Financial income (expenses), net
|
35 | - | 35 | (40 | ) | - | (40 | ) | (4 | ) | - | (4 | ) | (24 | ) | - | (24 | ) | ||||||||||||||||||||||||||||||
Taxes on income (3)
|
(409 | ) | (85 | ) | (494 | ) | (377 | ) | - | (377 | ) | (759 | ) | (168 | ) | (927 | ) | (569 | ) | (91 | ) | (660 | ) | |||||||||||||||||||||||||
Other
|
(5 | ) | - | (5 | ) | 3 | - | 3 | (26 | ) | - | (26 | ) | 5 | - | 5 | ||||||||||||||||||||||||||||||||
Net income
|
1,293 | 221 | 1,514 | 999 | 179 | 1,178 | 1,954 | 434 | 2,388 | 1,603 | 288 | 1,891 | ||||||||||||||||||||||||||||||||||||
Less: Net (income) loss attributable to the noncontrolling interest
|
- | - | - | 3 | - | 3 | (10 | ) | - | (10 | ) | 3 | - | 3 | ||||||||||||||||||||||||||||||||||
Net income attributable to Cimatron's shareholders
|
$ | 1,293 | $ | 221 | $ | 1,514 | $ | 1,002 | $ | 179 | $ | 1,181 | $ | 1,944 | $ | 434 | $ | 2,378 | $ | 1,606 | $ | 288 | $ | 1,894 | ||||||||||||||||||||||||
Net income per share - basic and diluted
|
$ | 0.12 | $ | 0.14 | $ | 0.11 | $ | 0.13 | $ | 0.18 | $ | 0.22 | $ | 0.17 | $ | 0.20 | ||||||||||||||||||||||||||||||||
Weighted average number of shares outstanding
|
||||||||||||||||||||||||||||||||||||||||||||||||
Basic EPS (in thousands)
|
10,751 | 10,751 | 9,362 | 9,362 | 10,741 | 10,741 | 9,355 | 9,355 | ||||||||||||||||||||||||||||||||||||||||
Diluted EPS (in thousands)
|
10,761 | 10,761 | 9,362 | 9,362 | 10,744 | 10,744 | 9,360 | 9,360 |
June 30,
|
December 31,
|
|||||||
2014
|
2013
|
|||||||
ASSETS
|
||||||||
CURRENT ASSETS:
|
||||||||
Total cash, cash equivalents and short-term investments
|
$ | 20,427 | $ | 13,052 | ||||
Trade receivables
|
4,971 | 6,838 | ||||||
Other current assets
|
2,423 | 2,434 | ||||||
Total current assets
|
27,821 | 22,324 | ||||||
Deposits with insurance companies and severance pay fund
|
3,820 | 3,725 | ||||||
Net property and equipment
|
1,021 | 977 | ||||||
Net other assets
|
10,113 | 10,407 | ||||||
Total assets
|
$ | 42,775 | $ | 37,433 | ||||
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
||||||||
CURRENT LIABILITIES:
|
||||||||
Short-term bank credit
|
$ | 13 | $ | 5 | ||||
Trade payables
|
1,035 | 1,356 | ||||||
Accrued expenses and other liabilities
|
5,592 | 6,297 | ||||||
Deferred revenues
|
7,107 | 2,974 | ||||||
Total current liabilities
|
13,747 | 10,632 | ||||||
LONG-TERM LIABILITIES:
|
||||||||
Accrued severance pay
|
5,186 | 5,018 | ||||||
Deferred tax liability
|
- | 69 | ||||||
Total long-term liabilities
|
5,186 | 5,087 | ||||||
Total shareholders’ equity
|
23,842 | 21,714 | ||||||
Total liabilities and shareholders’ equity
|
$ | 42,775 | $ | 37,433 |
Noncontrolling
Interest
|
Share
capital
|
Additional
paid-in capital
|
Accumulated
other
comprehensive
income
|
Retained
earnings
|
Treasury stock
|
Comprehensive
income
|
Total
shareholders’
equity
|
|||||||||||||||||||||||||
Balance at December 31, 2013
|
$ | 33 | $ | 350 | $ | 17,172 | $ | 88 | $ | 4,823 | $ | (752 | ) | $ | 21,714 | |||||||||||||||||
Changes during the six
months ended June 30, 2014:
|
||||||||||||||||||||||||||||||||
Net income
|
10 | 1,944 | 1,954 | 1,954 | ||||||||||||||||||||||||||||
Issuance of Restricted Shares
|
1 | 1 | ||||||||||||||||||||||||||||||
Stock based compensation
|
308 | 308 | ||||||||||||||||||||||||||||||
Other
|
(43 | ) | (148 | ) | (191 | ) | (191 | ) | ||||||||||||||||||||||||
Foreign currency translation adjustment
|
56 | 56 | 56 | |||||||||||||||||||||||||||||
Total comprehensive income
|
1,819 | |||||||||||||||||||||||||||||||
Balance at June 30, 2014
|
$ | - | $ | 351 | $ | 17,480 | $ | (4 | ) | $ | 6,767 | $ | (752 | ) | $ | 23,842 |
Six months ended
|
||||||||
June 30,
|
||||||||
2014
|
2013
|
|||||||
Cash flows from operating activities:
|
||||||||
Net income
|
$ | 1,954 | $ | 1,603 | ||||
Adjustments to reconcile net income
|
||||||||
to net cash provided by operating activities:
|
||||||||
Depreciation and amortization
|
475 | 557 | ||||||
Increase in accrued severance pay
|
142 | 232 | ||||||
Stock based compensation
|
308 | - | ||||||
Deferred taxes, net
|
(178 | ) | (90 | ) | ||||
Changes in assets and liabilities:
|
||||||||
Decrease (increase) in accounts receivable and prepaid expenses
|
1,910 | (258 | ) | |||||
Increase in inventory
|
(1 | ) | (8 | ) | ||||
Increase in deposits with insurance companies and severance pay fund
|
(95 | ) | (122 | ) | ||||
Increase in trade payables, accrued expenses and other liabilities
|
3,132 | 1,264 | ||||||
Net cash provided by operating activities
|
7,647 | 3,178 | ||||||
Cash flows from investing activities:
|
||||||||
Proceeds from sale of property and equipment
|
- | 9 | ||||||
Purchase of property and equipment
|
(175 | ) | (83 | ) | ||||
Net cash used in investing activities
|
(175 | ) | (74 | ) | ||||
Cash flows from financing activities:
|
||||||||
Short-term bank credit
|
8 | 2,499 | ||||||
Purchase of non-controlling interest
|
(92 | ) | - | |||||
Cash distribution to shareholders
|
- | (7,916 | ) | |||||
Proceeds from issuance of restricted shares
|
1 | 47 | ||||||
Net cash used in financing activities
|
(83 | ) | (5,370 | ) | ||||
Net increase (decrease) in cash and cash equivalents
|
7,389 | (2,266 | ) | |||||
Effect of exchange rate changes on cash
|
(14 | ) | (60 | ) | ||||
Cash and cash equivalents at beginning of period
|
13,052 | 11,903 | ||||||
Cash and cash equivalents at end of period
|
$ | 20,427 | $ | 9,577 | ||||
Appendix A - Non-cash transactions
|
||||||||
Purchase of property on credit
|
$ | 54 | $ | 122 |
$W,XU8>C6:#R;D!!5]X/)<06E/6K"4H0BDYI8$&9PX$J
MM0$5/P(EQ!:4*@`V-THD5#RC%G1JC-.`?H`ESK^'_4%,LO"LI"0H0;Q@1JTZ
MI\9P3)6[F;FW"WNTN(+2BU9LP92A"*^*.4X?"T;[YYK':$P43`/?6,W8;J
MU1:56BQ22 <6$X7H7X)%_,:4(V'*\)/N7X-L`36.IE$@RW?^)'P4J@HEF'0"?;$ST;>C>
MH?-CM>-EYZ/F^JZ3<+#74U]GE;*)7"B.'A(Y
M$JN:C>W>\":()N,174?]!A4]H""'_4-D]IY^D0^^7+O;[9YTNS]\_^/W_JM>
MD><,HNT0-,6KW>F
2!=(.SB"QLD.VF#2I*QIT]9)6RW;K"^XT\WYGC"VENPL
M_CZGL?/FS&7GY.)%&CNUL&-K.[;2U.#9DRD*0Y/L(&,<8[Z4%3]F\=%]0.
M?#:8,25-,,&G*H&AAQZ8/(#DMQS-TJV_````__\#`%!+`P04``8`"````"$`
M5GO5Q?D$``"^%```&````'AL+W=O
465S4:Q-ORQ"[3;DILI$TC6[?;DIIX`G&F92-?M\*GFTISX*^?2&-
M*^P;K<54ZCGJFT?V3'(=,S.LH)?`KW$)<@+2EY-^O>JLH8V`ZWE?R!\K0X8'
MT`KO*@E/2?A*(E`2H9*(E$3\B!#DAMVH+_?C[*6PF+VF_'$R9-%F+UK.KI/,
M-&9FBYFE]/2X\9HCII2$OAH)U$C($#Y(2QIDI/80BQYZ80KBPM;PO+@4%L5=
M2@)M&=*I)RX;+K?=%\_C"-W,I%W(Y[;[S0,U$JJ12(W$#Q%!8#C!/"\PA26!
M)16V#&$"FQ,I^5QNO:^1IT9\CM!9N.DCX-;[?81J)%(C\4-$$)E>XGKGJ<=+
M!(5%D4WID+%E"!-YA);2'+B"V9*V&8];[^OCJY&`(W0.1LB2)CKDYON=1&HD
MY@CKI!>GH"Z<4/OJ/K??T4:BRDMIP]TRA*DL'Z%<;KP?H*=&?#42<(1J((\B
MY,;[HXC42,P1J0M!9`3GSK[*CW.XI25YI3S<=@SLLP,'&K;7J1%/C?AJ)%`C
MH1J)U$C<(=W&N4#7,Y:H-KTC/+UBP+O%33)+._*V8[I#L;FPI&QW.Z`_'?+9
MP1.
CONSOLIDATED STATEMENTS OF INCOME (USD $)
In Thousands, except Per Share data, unless otherwise specified |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2014
|
Jun. 30, 2013
|
Jun. 30, 2014
|
Jun. 30, 2013
|
|
CONSOLIDATED STATEMENTS OF INCOME [Abstract] | ||||
Total revenue | $ 11,754 | $ 11,039 | $ 22,717 | $ 21,197 |
Total cost of revenue | 1,450 | 1,391 | 2,953 | 2,717 |
Gross profit | 10,304 | 9,648 | 19,764 | 18,480 |
Research and development expenses | 1,871 | 1,758 | 3,786 | 3,486 |
Selling, general and administrative expenses | 6,761 | 6,477 | 13,235 | 12,803 |
Operating income | 1,672 | 1,413 | 2,743 | 2,191 |
Financial income (expenses), net | 35 | (40) | (4) | (24) |
Taxes on income | (409) | (377) | (759) | (569) |
Other | (5) | 3 | (26) | 5 |
Net income | 1,293 | 999 | 1,954 | 1,603 |
Less: Net (income) loss attributable to the noncontrolling interest | 3 | (10) | 3 | |
Net income attributable to Cimatron's shareholders | $ 1,293 | $ 1,002 | $ 1,944 | $ 1,606 |
Net income per share - basic and diluted | $ 0.12 | $ 0.11 | $ 0.18 | $ 0.17 |
Weighted average number of shares outstanding | ||||
Basic EPS (in thousands) | 10,751 | 9,362 | 10,741 | 9,355 |
Diluted EPS (in thousands) | 10,761 | 9,362 | 10,744 | 9,360 |
@W:G1EHX8P%>FW6;1SFX4HA>@W2;1ZDX0HM>B7@-JW!"1*%[HVL>.(4T6F
MT-YF6C5'VTB+CS;T<[2NS-'XJD4_1^O@'(VOBO1SM-;/T;@J1#]'Z\H M(@[`+J7CLMT[]SI+[%!
M=]!Z&:1VFND"KQLY%]((_\*^S#5*X,G_`U!+`P04````"`"V,`U%+U)8,RH%
M```:'@``$0`<`&-I;70M,C`Q-#`V,S`N>'-D550)``-W..M3=SCK4W5X"P`!
M!"4.```$.0$``.U9W7/:1A!_[TS_AZM>VCP(01R[-6.2RB!L3;!($9FT>]V!U_Q_\BNU.V<3W@X3OPDCJ`E5;"^0@/
MACYS;?P'/@SQ:FW(V=WPTO+][ZCD/UN;'>R,QB-Y\00F"&*ZWU#*O0>J6(I(
M>W:J[ZC:7"`5^L:-RB3[;G&4C:@'S#+)5`0Y1V"UTP3Z^57./M(W7MU<('95
M:.7T*3?`
FI$30*C.LB#UI,PV'#U'__O*L8!7
MRC9PO-<][%0\X\5+1=8Z(LARL@,7M_@HS6R5*R"GYX7*6'<^(+"#0I:D@:"3MDL8FBQVM>P>V=$Q!OLN5TL)"H+A%GT_04$F&I..U<-S
M`#$G/2OCBUW&?QI/KG"7[/*D.O5=4MUTUI\-OP_'LZDTN9<&W_KCK\.I-!I+
MTV_]I^&WR=\&GZK]+POWZ,9G^)Z.)(L]OUP7;M5YJ])'1D^\F.)TRG0-(=
M._L);1&;FL\DJ($S)J`),^UE)SD0/5Y2*@`'A1I#";"<)<1D62X:BM
^ESA7GAP^B+-L!<%A3UK")=0$-_1FV'.XUK[\>DQPIL!*.V=E0,9]!9F
M3&\+0WFH]8.BD`H.FLJ;)G'8\6:W)=G-V)]:LH>,8Y093`Q0````(`+8P#44O
M4E@S*@4``!H>```1`!@```````$```"D@2QE``!C:6UT+3(P,30P-C,P+GAS
M9%54!0`#=SCK4W5X"P`!!"4.```$.0$``%!+!08`````!@`&`!H"``"A:@``
"````
`
end
Document And Entity Information
|
6 Months Ended |
---|---|
Jun. 30, 2014
|
|
Document And Entity Information [Abstract] | |
Document Type | 6-K |
Amendment Flag | false |
Document Period End Date | Jun. 30, 2014 |
Document Fiscal Year Focus | 2014 |
Document Fiscal Period Focus | Q2 |
Entity Registrant Name | CIMATRON LTD |
Entity Central Index Key | 0001008595 |
Current Fiscal Year End Date | --12-31 |
Entity Filer Category | Non-accelerated Filer |
CONSOLIDATED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified |
Jun. 30, 2014
|
Dec. 31, 2013
|
---|---|---|
CURRENT ASSETS: | ||
Total cash, cash equivalents and short-term investments | $ 20,427 | $ 13,052 |
Trade receivables | 4,971 | 6,838 |
Other current assets | 2,423 | 2,434 |
Total current assets | 27,821 | 22,324 |
Deposits with insurance companies and severance pay fund | 3,820 | 3,725 |
Net property and equipment | 1,021 | 977 |
Net other assets | 10,113 | 10,407 |
Total assets | 42,775 | 37,433 |
CURRENT LIABILITIES: | ||
Short-term bank credit | 13 | 5 |
Trade payables | 1,035 | 1,356 |
Accrued expenses and other liabilities | 5,592 | 6,297 |
Deferred revenues | 7,107 | 2,974 |
Total current liabilities | 13,747 | 10,632 |
LONG-TERM LIABILITIES: | ||
Accrued severance pay | 5,186 | 5,018 |
Deferred tax liability | 69 | |
Total long-term liabilities | 5,186 | 5,087 |
Total shareholders' equity | 23,842 | 21,714 |
Total liabilities and shareholders' equity | $ 42,775 | $ 37,433 |
STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (USD $)
In Thousands, unless otherwise specified |
Total
|
Noncontrolling interest [Member]
|
Share capital [Member]
|
Additional paid-in capital [Member]
|
Accumulated other comprehensive income [Member]
|
Retained earnings [Member]
|
Treasury stock [Member]
|
Comprehensive income [Member]
|
---|---|---|---|---|---|---|---|---|
Balance at Dec. 31, 2013 | $ 21,714 | $ 33 | $ 350 | $ 17,172 | $ 88 | $ 4,823 | $ (752) | |
Changes during the six months ended June 30, 2014: | ||||||||
Net income | 1,954 | 10 | 1,944 | 1,954 | ||||
Issuance of Restricted Shares | 1 | 1 | ||||||
Stock based compensation | 308 | 308 | ||||||
Other | (191) | (43) | (148) | (191) | ||||
Foreign currency translation adjustment | 56 | 56 | 56 | |||||
Total comprehensive income | 1,819 | |||||||
Balance at Jun. 30, 2014 | $ 23,842 | $ 351 | $ 17,480 | $ (4) | $ 6,767 | $ (752) |